Sound Pharmaceuticals, Incorporated
Sound Pharmaceuticals, Incorporated
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SPI-1005 for the Treatment of Meniere's Disease (Open Label) | Dizziness, Ear Diseases, Meniere disease, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Vertigo, endolymphatic hydrops, hearing disorder, hearing loss disorder, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, tinnitus, vestibular disorder | Active, not recruiting | Phase 3 | 2026-07-13 | NCT06859788 | |
| SPI-1005 in Adults Receiving Cochlear Implant | Ear Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease | Recruiting | Phase 2 | 2026-06-26 | NCT06340633 | |
| SPI-1005 Treatment in Moderate COVID-19 Patients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Enrolling by invitation | Phase 2 | 2023-10-03 | NCT04484025 |